stockrowPACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) EBITDA
PACS Group, Inc.'s EBITDA for fiscal 2025 was $368.4M, up 120.6% from $167.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $500.6M. Over the past ten years it has ranged from $91.4M (fiscal 2021) to $368.4M (fiscal 2025) — the current reading is the highest in ten years. PACS Group, Inc. ranks 12th of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $368.4M | 120.61% |
| FY2024 | $167.0M | (30.26%) |
| FY2023 | $239.5M | (5.30%) |
| FY2022 | $252.9M | 176.63% |
| FY2021 | $91.4M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $120.6M | (7.41%) |
| Jun 2026 | $130.2M | (6.23%) |
| Mar 2026 | $138.9M | 25.30% |
| Dec 2025 | $110.9M | 9.26% |
| 11 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $3.8B |
| DVA DaVita Inc. compare | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| ENSG The Ensign Group, Inc. compare | $630.9M |
| PACS PACS Group, Inc. | $500.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $479.6M |
| CHE Chemed Corporation compare | $438.8M |
| OPCH Option Care Health, Inc. compare | $408.3M |
| LFST LifeStance Health Group, Inc. compare | $161.1M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PACS
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement